RxDoctor Payments Data

Jeffrey Friedman

Family Medicine · Deland, FLNPI 1821089699

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.3% of the total across 129 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 22.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $899 and has fallen 93.7% since, to $56 in 2022.

$1,897in general payments, 2019–2025

Across 129 payments — averaging $14.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$426
  • Amarin Pharma, Inc.$209
  • Amgen$208
  • Pfizer$202
  • Novo Nordisk$194
  • GSK$130
  • plus $528 from 12 others

What the payments were for

  • Food & beverage$1,88399%
  • Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,897 in reported general payments places this provider in the 75th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone14$229
Atorvastatin Calcium19$229
Levothyroxine Sodium12$122

Paid to pharmacies, not to this prescriber.

Other family medicine in Deland

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →